Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 237 publications
Cholangiocarcinoma - Morphology, Immunohistochemistry, and Genetics.
Journal: Ceskoslovenska patologie
Published: October 16, 2025
Rare gliomas: standard treatment approaches and new target therapies.
Journal: Current opinion in neurology
Published: September 24, 2025
Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1.
Journal: International journal of molecular sciences
Published: September 17, 2025
Perioperative and precision strategies in resectable intrahepatic cholangiocarcinoma.
Journal: Global health & medicine
Published: September 03, 2025
Identifying Drug Combination Strategies for ZMYM2: FGFR1 Fusion Positive Leukemia.
Journal: Precision oncogenomics
Published: August 29, 2025
Molecular Mechanisms and Clinical Implications of Fibroblast Growth Factor Receptor 2 Signaling in Gastrointestinal Stromal Tumors.
Journal: Current issues in molecular biology
Published: August 27, 2025
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement.
Journal: NEJM evidence
Published: August 26, 2025
Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutation.
Journal: The oncologist
Published: August 18, 2025
Next-generation isoform-selective fibroblast growth factor receptor inhibitors.
Journal: Trends in pharmacological sciences
Published: August 14, 2025
Remarkable response of gastric adenocarcinoma with FGFR2-TRIM44 fusion to pemigatinib: a case report.
Journal: Japanese journal of clinical oncology
Published: August 10, 2025
Economic and clinical outcomes among patients with cholangiocarcinoma receiving pemigatinib with or without history of cancer of unknown primary.
Journal: The oncologist
Published: July 25, 2025
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program.
Journal: Current oncology (Toronto, Ont.)
Published: July 04, 2025
Last Updated: 01/07/2026